References
- Nahorski S R. Identification and significance of β-adrenoceptor subtypes. Trends Pharm Sci 1981; 95–98
- Ross E M, Gilman A G. Biochemical properties of hormone-sensitive adenylate cyclase. Ann Rev Biochem 1980; 49: 533–564
- Cornett L E, Norris J S. Characterization of the α1-adrenergic receptor subtype in a smooth muscle cell line. J Biol Chem 1982; 257: 694–697
- Cornett L E, Ball D W, Norris J S. α1-adrenergic receptors of a smooth muscle cell line: guanine nucleotides do not regulate agonist affinities. J Receptor Res 1982; 2: 601–610
- Norris J S, Kohler P O. Androgen receptors in a Syrian hamster ductus deferens tumor cell line. Nature 1974; 248: 422–424
- Norris J S, Kohler P O. The coexistence of androgen and glucocorticoid receptors in the DDT1 cloned cell line. Endocrinology 1977; 100: 613–618
- Bradford M M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1973; 72: 248–254
- Cheng Y, Prusoff W H. Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 percent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 2108; 22: 2099–2108
- Salomon Y, Londos C, Rodbell M. A highly sensitive adenylate cyclase assay. Anal Biochem 1974; 58: 541–548
- Gilman A G. A protein binding assay for adenosine 3′,5′-cyclic monophosphate. Proc Natl Acad Sci USA 1970; 67: 305–309
- Ahlquist R P. Study of adrenotropic receptors. Am J Physiol 1948; 153: 586–600
- Lands A M, Arnold A, Mc Auliff J D, Luduena F P, Brown T G. Differentiation of receptor systems activated by aympathomimetic amines. Nature 1967; 214: 597–598
- Lefkowitz R J. Identification of β-adrenergic receptors. Hormone-receptor Interaction: Molecular Aspects, G Levey. Marcel Dekker, Inc., New York 1976; 333–348
- Spiegel A M, Downs R W, Jr. Guanine nucleotides: key regulators of hormone receptor-adenylate cyclase interaction. Endocrine Rev 1981; 2: 275–305
- Fortier M, Chase D, Korenman S G, Krall J F. β-adrenergic catecholamine-dependent properties of rate myometrium primary cultures. Am J Physiol 1983; 245, in press
- Insel P A, Stoolman L H. Radioligand binding to β-adrenergic receptors of intact cultured S49 cells. Molec Pharmacol 1978; 14: 549–561
- Terasaki W L, Brooker G. [125I]-iodolydroxybenzylpindolol binding sites on intact rat glioma cells. J Biol Chem 5425; 253: 5418–5425
- Pittman R N, Molinoff P B. Interactions of agonists and antagonists with β-adrenergic receptors on intact L6 muscle cells. J Cycl Nuc Res 1980; 6: 421–435
- Franklin T J, Twose P A. Reduction of β-adrenergic response of cultured glioma cells following depletion of intracellular GTP. Eur J Biochem 1977; 77: 113–117
- Johnson G S, Mukku V R. Evidence in intact cells for an involvement of GTP in the activation of adenylate cyclase. J Biol Chem 1970; 654: 95–100
- Hughes R J, Boyle M R, Brown R D, Taylor P, Insel P A. Characterization of coexisting α1- and β2-adrenergic receptors on a cloned muscle cell line, BC3H-1. Molec Pharmacol 1982; 22: 258–266
- Kirkman H, Algard F T. Autonomous variants of an androgen/ estrogen induced and -dependent ductus deferens leiomyosarcoma of the Syrian hamster. Cancer Res 1970; 30: 35–40
- Lefkowitz R J. Heterogeneity of adenylate cyclase-coupled β-adrenergic receptors. Biochem Pharmacol 1975; 24: 583–590
- Lefkowitz R J, Sharp G, Haber E. Specific binding of β-adrenergic catecholamines to subcellular fraction from cardiac muscle. J Biol Chem 1973; 248: 342–349